Clinical Trial Update: Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for topical BMX-010 in subjects with psoriasis and atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Psoriasis

Drugs mentioned

• BMX-010

Snippet

Sponsor: BioMimetix JV, LLC | Conditions: Psoriasis, Atopic Dermatitis | Phase 2 | Status: COMPLETED